Drug Pipeline News

Latest News

OpGen announces positive topline clinical trial data for UTI panel
OpGen announces positive topline clinical trial data for UTI panel

December 20th 2022

The precision medicine company announced successful completion of its Unyvero urinary tract infection (UTI) clinical trial with promising results and plans for submission to the FDA.

Dostarlimab shows positive results in phase 3 trial for endometrial cancer
Dostarlimab shows positive results in phase 3 trial for endometrial cancer

December 2nd 2022

FDA approves ibrexafungerp for reduction in the incidence of RVVC
FDA approves ibrexafungerp for reduction in the incidence of RVVC

December 1st 2022

FDA grants accelerated approval to mirvetuximab soravtansine-gynx for ovarian cancer
FDA grants accelerated approval to mirvetuximab soravtansine-gynx for ovarian cancer

November 17th 2022

Dare Bioscience announces grant to develop vaginal thermosetting gel for delivery of live biotherapeutics
Dare Bioscience announces grant to develop vaginal thermosetting gel for delivery of live biotherapeutics

November 16th 2022

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.